abstract |
The invention relates to the application of MTH2 protein as a colorectal cancer therapeutic target, and belongs to the fields of molecular biology and biomedicine. Application of MTH2 protein as a therapeutic target for colorectal cancer. The present invention provides a new therapeutic target for colorectal cancer, which can be effectively used for colorectal cancer development judgment, treatment plan selection and/or prognosis evaluation, thereby providing a novel colorectal cancer diagnostic agent in the art and/or therapeutic agents, which have clinical application prospects. |